Alan Davies - Huabao International Executive
| HUIHYDelisted Stock | USD 14.60 0.00 0.00% |
Executive
Mr. Alan Davies is Chief Flavourist of Huabao Flavors and General Manager Of Aromas cape Development Centre In Germany of the Company. He joined the Group since February 2007. Mr. Davies is also a director of the Companys principal subsidiaries marked with AD1 as set out in Note 33 to the consolidated financial statements. Mr. Davies holds a Higher National Diploma in food science of Grimsby College of Technology, United Kingdom. Mr. Davies served as a senior flavourist in charge of creation and applications in a number of world renowned flavours and fragrances companies and tobacco factory, including BBA, Carreras Rothmans, Dragoco and Symrise since 2017.
| Age | 75 |
| Tenure | 7 years |
| Phone | 852 2877 8999 |
| Web | https://www.hbglobal.com |
Huabao International Management Efficiency
The company has return on total asset (ROA) of 0.0421 % which means that it generated a profit of $0.0421 on every $100 spent on assets. This is way below average. Huabao International's management efficiency ratios could be used to measure how well Huabao International manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Peter Buhler | Valneva SE ADR | 53 | |
| Manny Panesar | Celestica | N/A | |
| Alok Agrawal | Celestica | N/A | |
| Howard Cyr | Teleflex Incorporated | N/A | |
| Nancy Grygiel | Amgen Inc | 56 | |
| Michelle Fox | Teleflex Incorporated | N/A | |
| JuanCarlos MD | Valneva SE ADR | 52 | |
| Derek Miller | Amgen Inc | 51 | |
| John Weaver | IPG Photonics | N/A | |
| Frederic Jacotot | Valneva SE ADR | 60 | |
| Susanne EderLingelbach | Valneva SE ADR | N/A | |
| Sylke Maas | BioNTech SE | N/A | |
| Alan Russell | Amgen Inc | N/A | |
| Zach Taylor | BioNTech SE | N/A | |
| CPA CMA | Celestica | 47 | |
| Oliver Henning | BioNTech SE | N/A | |
| Justin Claeys | Amgen Inc | N/A | |
| Paul Carpino | Celestica | N/A | |
| Jerry Murry | Amgen Inc | N/A | |
| Mike Zahigian | Amgen Inc | N/A | |
| Gideon Kedem | Valens | 65 | |
Management Performance
| Return On Equity | 0.0056 | |||
| Return On Asset | 0.0421 |
Huabao International Leadership Team
Elected by the shareholders, the Huabao International's board of directors comprises two types of representatives: Huabao International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Huabao. The board's role is to monitor Huabao International's management team and ensure that shareholders' interests are well served. Huabao International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Huabao International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Guang Wang, Consultant | ||
| Lam Chu, Chairwoman, CEO and Chairwoman of Nomination Committee | ||
| Gao Xu, Pres Division | ||
| Man Choy, Director of Tobacco Flavours and Fragrances Centre | ||
| Ka Lam, Non-Executive Director | ||
| Liqun Xia, Pres Chairman | ||
| Alan Davies, Chief Technical Officer of Tobacco Flavours, General Manager of Aromascape R&D Centre | ||
| ACIS ACS, Company VP | ||
| Xiao Yuan, Assistant to the President of the Group, Vice General Manager of Guangdong Jinye |
Huabao Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Huabao International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0056 | |||
| Return On Asset | 0.0421 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 1.04 B | |||
| Shares Outstanding | 64.6 M | |||
| Price To Earning | 27.14 X | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 3.88 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Huabao Pink Sheet
If you are still planning to invest in Huabao International check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Huabao International's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |